Puma Biotechnology (PBYI) EPS (Basic) (2010 - 2026)
Puma Biotechnology (PBYI) posted EPS (Basic) of -$0.07 for Q1 2026, down 121.89% on a QoQ basis from $0.34 in Q4 2025, and down 223.09% year-over-year from $0.06 in Q1 2025.
Puma Biotechnology (PBYI) EPS (Basic) (2010 - 2026) Analysis & Trends
Puma Biotechnology's EPS (Basic) history runs 17 years deep, the most recent figure standing at -$0.07 for Q1 2026.
- Quarterly EPS (Basic) fell 223.09% year-over-year to -$0.07 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $0.55 (up 256.25% YoY) and the FY2025 annual result came in at $0.69, up 19296.54% from the prior year.
- EPS (Basic) was -$0.07 for Q1 2026 at Puma Biotechnology, down from $0.34 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.41 in Q3 2024 and bottomed at -$0.23 in Q4 2024.
- A 5-year average of $0.06 and a median of $0.05 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) soared 1643.85% — and 2024, when it plunged 432.61%.
- Puma Biotechnology's EPS (Basic) stood at -$0.12 in 2022, then jumped by 329.01% to $0.26 in 2023, then slumped by 186.78% to -$0.23 in 2024, then surged by 247.13% to $0.34 in 2025, then tumbled by 121.89% to -$0.07 in 2026.
- Business Quant data shows PBYI's EPS (Basic) at -$0.07 in Q1 2026, $0.34 in Q4 2025, and $0.18 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Puma Biotechnology | 406.51 Mn | 368.22 Mn | 34.39 Mn | -0.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.07 |
| Dec 31, 2025 | 0.34 |
| Sep 30, 2025 | 0.18 |
| Jun 30, 2025 | 0.12 |
| Mar 31, 2025 | 0.06 |
| Dec 31, 2024 | -0.23 |
| Sep 30, 2024 | 0.41 |
| Jun 30, 2024 | -0.09 |
| Mar 31, 2024 | -0.10 |
| Dec 31, 2023 | 0.26 |
| Sep 30, 2023 | 0.12 |
| Jun 30, 2023 | 0.05 |
| Mar 31, 2023 | 0.03 |
| Dec 31, 2022 | -0.12 |
| Sep 30, 2022 | -0.01 |
| Jun 30, 2022 | 0.21 |
| Mar 31, 2022 | -0.08 |
| Dec 31, 2021 | 0.10 |
| Sep 30, 2021 | -1.09 |
| Jun 30, 2021 | -0.13 |